Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 14.03.2024
Aignostics GmbH
Bayer and Aignostics to collaborate on next generation precision oncologyNot intended for UK Media
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio
Co-development of a novel target identific [ … ]
Thu, 14.03.2024
Hapag-Lloyd AG
Supervisory Board renews appointment of Rolf Habben Jansen and extends contract of Donya-Florence Amer
The Supervisory Board of Hapag-Lloyd AG has approved an early renewal of the contract of Chief Executive Officer (CEO) Rolf Habben Jansen, which runs until 31 March 2027, for five years, until 31 March 2029. In addition, the Supervisory Board has [ … ]
Thu, 14.03.2024
ecotel communication ag
Revenues: € 106.3 million (+14%)
Gross profit: € 32.1 million (+6%)
Operating EBITDA: € 9.0 million (+2%)
Adjusted EPS: € 0.94 (previous year: € 1.39)
Dividend proposal: 50% of adjusted EPS (€ 0.47 per share)
Two major orders secured with TCV of > € 20 million
Double-digit annual growth in B2B business forecast from 2024 to 2026
Düsseldorf [ … ]
Thu, 14.03.2024
DFV Deutsche Familienversicherung AG
Corporate News
Preliminary financial result 2023
Deutsche Familienversicherung: Profitability target achieved and new business target exceeded
New business volume of EUR 19 million in 2023, well above plan of EUR 15 million
Insurance sales increase by 7% to EUR 118 million
Robust operating result of EUR 8.5 million (2022; EUR 8.0 million)
Con [ … ]
Thu, 14.03.2024
Epigenomics AG
Epigenomics AG publishes financial results for fiscal year 2023
Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial results (according to HGB) for fiscal year 2023.
OPERATIONAL DEVELOPMENTS
Due to the lack of necessary financing for the further development of the Epi proColon “Next-Gen” test and t [ … ]
Thu, 14.03.2024
VERBUND AG
The VERBUND Group’s strategic and economic development in 2023 took place in a highly complex environment that was impacted in no small measure by geopolitical turmoil and macro- and microeconomic factors, along with sector-specific developments and regulatory/political decisions. Overall, 2023 was a very successful year for our Group, and as a str [ … ]
Thu, 14.03.2024
Elmos Semiconductor SE
Preliminary financial figures and guidance confirmed – dividend proposal raised to 0.85 Euro per share – own climate targets for 2023 achieved
Dortmund, March 14, 2024: Elmos Semiconductor SE (FSE: ELG) today published its financial statements and Annual Report for fiscal year 2023. The preliminary financials and the guidance from mid-February ar [ … ]
Thu, 14.03.2024
Dermapharm Holding SE
Dermapharm Holding SE hits upper end of guidance range
for adjusted EBITDA, primarily due to steadily growing
international presence in branded business
» Consolidated revenue up 10.8% year on year to EUR 1,135.4 million
» Adjusted consolidated EBITDA declines by 13.8% to EUR 310.2 million
» Adjusted consolidated EBITDA margin: 27.3%
» Bo [ … ]
Thu, 14.03.2024
Hapag-Lloyd AG
Hapag-Lloyd publishes 2023 annual report and announces forecast for the current financial year
Third-best result in the company’s history achieved
Proposed dividend of EUR 9.25 per share
Outlook: market environment will remain challenging
Hapag-Lloyd today published its annual report for 2023. As expected, a significant decrease in earnings was [ … ]
Thu, 14.03.2024
Vitesco Technologies Group AG
Fiscal year 2023: Profitability and cash flow exceeded expectations
Sales increase to €9.23 billion in fiscal year 2023 (2022: €9.07 billion)
Adjusted EBIT margin came in higher than the company’s own guidance at 3.7 percent (2022: 2.5 percent)
Free cash flow above the company’s expectations at €84.9 million (2022: €123.2 million)
Growth in [ … ]